Danvanthiri Drug Development Centre Llp - Company Profile

It is a research & development limited liability partnership based in Coimbatore, Tamil Nadu, India, established in 2020.
2020 Coimbatore, Tamil Nadu, India Active
Last Updated:
About Danvanthiri Drug Development Centre Llp

Danvanthiri Drug Development Centre Llp, a active limited liability partnership, was established on 05 March 2020 in Coimbatore, Tamil Nadu, India. Engaging in research & development within the research & development sector, it holds LLPIN: AAS-1607. Registered under ROC Roc Coimbatore. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Dharmalingam Vetrivel (Designated Partner), Elango Hemnath (Designated Partner). Its latest date of accounts and solvency statement 31 March 2020. It is based at K 5/302E Sidco Indl. Estate, Kurichi,, Coimbatore, Tamil Nadu, 641021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAS-1607

  • Incorporation Date

    05 March 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Coimbatore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2020
Company report

Danvanthiri Drug Development Centre Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Danvanthiri Drug Development Centre Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Danvanthiri Drug Development Centre Llp?
Current Designated Partners
Name Designation Appointment Date Status
Dharmalingam Vetrivel Designated Partner 05 Mar 2020 Current
Elango Hemnath Designated Partner 05 Mar 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Danvanthiri Drug Development Centre Llp.

Enhance accessibility to Danvanthiri Drug Development Centre Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Danvanthiri Drug Development Centre Llp revenue growth over time
Danvanthiri Drug Development Centre Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Danvanthiri Drug Development Centre Llp?

Unlock access to Danvanthiri Drug Development Centre Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Danvanthiri Drug Development Centre Llp?

Unlock and access historical data on people associated with Danvanthiri Drug Development Centre Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Danvanthiri Drug Development Centre Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danvanthiri Drug Development Centre Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Danvanthiri Drug Development Centre Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Danvanthiri Drug Development Centre Llp last Annual general meeting of members was held on 31 Mar 2021 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Danvanthiri Drug Development Centre Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Coimbatore. was completed.

  • Director Appointment

    Progress on Dharmalingam Vetrivel was appointed as a Designated Partner was appointed as a Designated Partner on 05 Mar 2020 & has been associated with this company since 5 years 11 months . was documented.

  • Director Appointment

    The activity Elango Hemnath was appointed as a Designated Partner was appointed as a Designated Partner on 05 Mar 2020 & has been associated with this company since 5 years 11 months . was completed.

  • LLP Incorporation

    The activity Danvanthiri Drug Development Centre Llp was registered on 05 Mar 2020 with Roc Coimbatore & aged 5 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Danvanthiri Drug Development Centre Llp?

The LLPIN of Danvanthiri Drug Development Centre Llp is AAS-1607.

Where is Danvanthiri Drug Development Centre Llp headquartered?

Danvanthiri Drug Development Centre Llp is headquartered at K 5/302E Sidco Indl. Estate, Kurichi,, Coimbatore, Tamil Nadu, 641021.

When was Danvanthiri Drug Development Centre Llp incorporated?

Danvanthiri Drug Development Centre Llp was incorporated on 05 March 2020.

Who are the current directors of Danvanthiri Drug Development Centre Llp?

The current directors of Danvanthiri Drug Development Centre Llp are

What is the primary industry of Danvanthiri Drug Development Centre Llp?

The primary industry of Danvanthiri Drug Development Centre Llp is Research & Development.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available